British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults | Gut
Assessing, managing and monitoring biologic therapies for inflammatory arthritis
Medical management of moderate to severe luminal and perianal fistulizing Crohn's disease - American Gastroenterological Association
NASPGHAN17 Therapeutic Drug Monitoring Associated with Increased Clinical Remission | gutsandgrowth
Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus
PDF) Adalimumab and Anti-adalimumab Lisa-tracker Immunoassays Performance Criteria for Therapeutic Drug Monitoring of Adalimumab-amgen Biosimilar (Abp501)
IJMS | Free Full-Text | Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver
Immunopharmacologic Monitoring of Therapeutic Serum Antibodies I. Policy Description II. Related Policies III. Indications and/o
Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease
Frontiers | Advances in Therapeutic Drug Monitoring in Biologic Therapies for Pediatric Inflammatory Bowel Disease
New Zealand Society of Gastroenterology Guidelines on Therapeutic Drug Monitoring in Inflammatory Bowel Disease
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults | Gut
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations - Nast - 2020 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library
JCM | Free Full-Text | Therapeutic Drug Monitoring of Subcutaneous Infliximab in Inflammatory Bowel Disease—Understanding Pharmacokinetics and Exposure Response Relationships in a New Era of Subcutaneous Biologics
Adalimumab | Crohn's & Colitis UK
AGA Guideline: Therapeutic drug monitoring in IBD | GI and Hepatology News
Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities - ScienceDirect
New Zealand Society of Gastroenterology Guidelines on Therapeutic Drug Monitoring in Inflammatory Bowel Disease
Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives - Gastroenterology
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease | PLOS ONE
Proposed algorithm for proactive therapeutic drug monitoring of... | Download Scientific Diagram
1 Scottish Biologic Therapeutic Drug Monitoring Service –Gastroenterology Guidance The purpose of this document is to provide
Tumor Necrosis Factor (TNF) Inhibitors Therapeutic Cheat Sheet - Next Steps in Dermatology
Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers - eBioMedicine
Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives - The Lancet Gastroenterology & Hepatology
Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus
JCM | Free Full-Text | A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease
